3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
79
Stomach Neoplasms
66
Rectal Neoplasms
39
Pancreatic Neoplasms
29
Colonic Neoplasms
27
Esophageal Neoplasms
24
Lymphoma, Large B-Cell, Diffuse
20
Neoplasms
19
Adenocarcinoma
19
Neoplasm Metastasis
16
Cholangiocarcinoma
15
Adenocarcinoma Of Esophagus
14
Carcinoma, Non-Small-Cell Lung
12
Biliary Tract Neoplasms
12
Ovarian Neoplasms
11
Parkinson Disease 4, Autosomal Dominant Lewy Body
10
Gastrointestinal Neoplasms
7
Gallbladder Neoplasms
7
Carcinoma, Hepatocellular
7
Locally Advanced Rectal Cancer
6
Esophageal Squamous Cell Carcinoma
6
Endometrial Neoplasms
6
Triple Negative Breast Neoplasms
4
Recurrence
4
Lymphoma
4
Lung Neoplasms
4
Carcinoma
4
Bile Duct Neoplasms
4
Advanced Solid Tumors
4
Squamous Cell Carcinoma of Head and Neck
3
Interventions
pembrolizumab
59
Cisplatin
44
Cetuximab
27
Radiotherapy
26
Carboplatin
24
Paclitaxel
16
Nivolumab
16
Docetaxel
16
Surveys and Questionnaires
15
Radiotherapy, Intensity-Modulated
13
Fluorouracil
12
Drug Therapy
12
Blood Specimen Collection
11
tislelizumab
7
cemiplimab
6
atezolizumab
6
Standard of Care
6
Radiation
6
Chemoradiotherapy
6
toripalimab
4
nimotuzumab
4
dostarlimab
4
Surgical Procedures, Operative
4
Cyclophosphamide
4
Afatinib
4
130-nm albumin-bound paclitaxel
4
palbociclib
3
niraparib
3
fludarabine
3
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Oxaliplatin
×
1 year
×
Clear all
No trials found.